Citation

Petro JB, Plasse TR, McNulty JA. Biosecur. Bioterror. 2003; 1(3): 161-168.

Affiliation

Counterproliferation and Technology Office, Defense Intelligence Agency, Bolling AFB, Washington, DC, USA. James.petro@dia.mil

Copyright

(Copyright © 2003, Mary Ann Liebert Publishers)

DOI

10.1089/153871303769201815

PMID

15040194

Abstract

Advances in biological research likely will permit development of a new class of advanced biological warfare (ABW) agents engineered to elicit novel effects. In addition, biotechnology will have applications supporting ABW weaponization, dissemination, and delivery. Such new agents and delivery systems would provide a variety of new use options, expanding the BW paradigm. Although ABW agents will not replace threats posed by traditional biological agents such as Bacillus anthracis (anthrax) and Variola (smallpox), they will necessitate novel approaches to counterproliferation, detection, medical countermeasures, and attribution.

Language: en